Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

OPKO Health Inc (NYSE:OPK)

11.42
Delayed Data
As of Aug 28
 +0.30 / +2.70%
Today’s Change
8.02
Today|||52-Week Range
19.20
+14.31%
Year-to-Date

Today’s Trading

Previous close11.12
Today’s open11.18
Day’s range11.08 - 11.54
Volume4,122,223
Average volume (3 months)5,508,073
Market cap$6.2B
Dividend yield--
Data as of 4:02pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)-28.12%
Earnings growth (this year)+31.71%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-5.60%
P/E ratioNM
Price/Sales46.27
Price/Book5.86

Competitors

 Today’s
change
Today’s
% change
ANACAnacor Pharmaceutica...+1.83+1.37%
TAROTaro Pharmaceutical ...+0.30+0.22%
IDXXIDEXX Laboratories I...-0.21-0.29%
SGENSeattle Genetics Inc+1.01+2.45%
Data as of 4:14pm ET, 08/28/2015

Financials

Next reporting dateNovember 10, 2015
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$91.1M
Annual profit (last year)-$171.7M
Net profit margin-188.39%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Phillip Frost
Chief Financial Officer, Treasurer, CAO &
SVP
Adam E. Logal
Corporate headquarters
Miami, Florida

Forecasts

Partner Offers